MedTrace Logo

Role of Vitamin C to Augment Iron Chelation With DFP or DFX

NCT02083575 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2014-03-11

No results posted yet for this study

Summary

role of Vit C to Augment iron chelation with DFP or DFX in thalassemic patients.

Conditions

  • Vitamin c
  • Thalassemia Major
  • Iron Chelation

Interventions

DRUG

Vitamin C, Defriprone, deferisarox

adjuvant vitamin c with iron chelator.

DRUG

deferiprone , deferesarox

iron chelator

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • MOHSEN S ELALFY, PROF. · Ain Shams University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
6 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2014-04-30
Completion
2014-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02083575 on ClinicalTrials.gov